Us Bancorp \De\ 23and Me Holding Co. Transaction History

Us Bancorp \De\

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.71 - $0.97 $1,587 - $2,168	2,236 Added 67.82%	5,533 $5,000
Q2 2023 Aug 09, 2023	SELL	$1.59 - $2.29 $1,868 - $2,690	-1,175 Reduced 26.27%	3,297 $5,000
Q1 2023 May 09, 2023	SELL	$2.05 - $2.87 $313 - $439	-153 Reduced 3.31%	4,472 $10,000
Q4 2022 Feb 13, 2023	BUY	$2.06 - $3.47 $1,400 - $2,359	680 Added 17.24%	4,625 $9,000
Q3 2022 Oct 27, 2022	SELL	$2.6 - $5.12 $7,852 - $15,462	-3,020 Reduced 43.36%	3,945 $11,000
Q2 2022 Aug 01, 2022	SELL	$2.19 - $3.98 $114,867 - $208,754	-52,451 Reduced 88.28%	6,965 $17,000
Q1 2022 May 11, 2022	BUY	$3.28 - $7.12 $17,016 - $36,938	5,188 Added 9.57%	59,416 $229,000
Q4 2021 Feb 11, 2022	BUY	$6.55 - $13.25 $64,314 - $130,101	9,819 Added 22.11%	54,228 $361,000
Q3 2021 Nov 10, 2021	BUY	$7.29 - $11.0 $317,435 - $478,984	43,544 Added 5033.99%	44,409 $403,000
Q2 2021 Aug 05, 2021	BUY	$9.87 - $13.32 $8,537 - $11,521	865 New	865 $10,000

8.41M

50K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $158M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.